Imagion Biosystems has announced “Appendix 3B, New issue announcement, application for quotation of additional securities and agreement.”
Read Appendix 3B.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2